ReShape Lifesciences Inc.
NasdaqCM:RSLS
$ 0.18
+ $0.01 (5.88%)
$ 0.18
+ $0.01 (5.88%)
End-of-day quote: 05/17/2024

ReShape Lifesciences financials at a glance

The revenue of ReShape Lifesciences is reported as 0.00868 billion Dollars in the fiscal year 2023. The earnings were 0 Dollars per share in 2023, which was 92.89 higher than 2016. And about -0.0008 billion Dollars are reported as free cash flow in the financials of ReShape Lifesciences 2023. No dividends were paid to the shareholders of the ReShape Lifesciences stock NasdaqCM:RSLS in the financial year 2023.

Financials

Year Year TTM 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Rev. Revenue N/A $1.29M $0.00M $0.29M $0.00M $0.00M $0.31M $0.00M $0.00M $0.00M $0.00M $0.00M
GM % Gross Margin % 54.11% 41.44% 45.15% 57.44% 0.00% 0.00% 25.67% 0.00% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin -,183.32% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share $-11.73 $-33,608,870.97 $-472,908,266.13 $-3778,761,061.95 $-4875,000,000.00 $-5875,000,000.00 $-7375,000,000.00 $-10750,000,000.00 $-25750,000,000.00 $-107000,000,000.00 $-225000,000,000.00 $-1169000,000,000.00
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares N/AM 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M
OCF Operating Cash Flow N/A $-24.59M $0.00M $0.00M $-19.38M $-18.43M $-22.48M $-19.94M $-13.66M $-24.66M $-34.00M $-23.37M
FCF Free Cash Flow N/A $-24.73M $0.00M $-22.64M $-19.47M $-18.84M $-22.56M $-20.19M $-13.67M $-24.85M $-34.24M $-24.17M
FCFS Free Cash Flow Per Share $-7.83 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00